Pharmadrug Inc. (CSE:PHRX)

Canada flag Canada · Delayed Price · Currency is CAD
0.0150
+0.0050 (50.00%)
Jun 27, 2025, 2:09 PM EDT
0.00%
Market Cap 1.08M
Revenue (ttm) n/a
Net Income (ttm) -396.39K
Shares Out 108.23M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,428
Average Volume 68,667
Open 0.0050
Previous Close 0.0100
Day's Range 0.0050 - 0.0150
52-Week Range 0.0050 - 0.0550
Beta 1.62
RSI 47.25
Earnings Date Aug 8, 2025

About Pharmadrug

Pharmadrug Inc. operates as a specialty pharmaceutical company. The company focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally derived approved drugs. It also engages in the researching and reformulating of established natural medicines; development of synthetic formulations of existing drugs for potential commercialization and distribution; development of cepharanthine, a drug for the treatment of infectious disease and rare cancers; and rese... [Read more]

Sector Healthcare
Founded 2011
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PHRX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.